Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of MGC Cream in Healthy Volunteers
NCT02976779Phase 1Completed
- Sponsor
- One World Cannabis
- Start
- Feb 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nabiximols in psoriasis (2 arms), sponsored by One World Cannabis. Primary endpoint: Incidence rate of Adverse Events and Serious Adverse Events at 24 hours. Started Feb 2017; status: completed.
02
Drugs
nabiximols
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02976779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976779.